Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.nmni.2020.100745 http://scihub22266oqcxt.onion/10.1016/j.nmni.2020.100745 33088576!7567956!33088576     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       New+Microbes+New+Infect 2020 ; 38 (ä): 100745 Nephropedia Template TP {{tp|p=33088576|t=2020. Critical reappraisal of remdesivir investigational trials in COVID-19 |pdf=|usr=}}{{33088576}} gab.com Text Critical reappraisal of remdesivir investigational trials in COVID-19 JO: New Microbes New Infect http://www.kidney.de/pget.php?&tw=1&pmid=33088576 #FOAvip During disease outbreaks, the pharmaceutical industry generally puts a lot of effort into promoting clinical trials studying their new drugs. We review evidence of the ten most recent reports on remdesivir. We conclude that it is far too premature to identify remdesivir as a curative or life-saving intervention during the COVID-19 pandemic. Twit Text FOAVip Critical reappraisal of remdesivir investigational trials in COVID-19 ????New Microbes New Infect http://www.kidney.de/pget.php?&tw=1&pmid=33088576 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33088576 #FOAvip English Wikipedia <ref>{{Cite pmid|33088576}}</ref> Critical reappraisal of remdesivir investigational trials in COVID-19 #MMPMID33088576 Brouqui P; Giraud-Gatineau A; Raoult D New Microbes New Infect 2020[Nov]; 38 (ä): 100745 PMID33088576show ga During disease outbreaks, the pharmaceutical industry generally puts a lot of effort into promoting clinical trials studying their new drugs. We review evidence of the ten most recent reports on remdesivir. We conclude that it is far too premature to identify remdesivir as a curative or life-saving intervention during the COVID-19 pandemic. äCritical reappraisal of remdesivir investigational trials in COVID-19 (epmc).pdf DeepDyve Pubget Overpricing